Idiopathic hypertensive anal canal: a place of internal sphincterotomy
- PMID: 19517198
- DOI: 10.1007/s11605-009-0931-6
Idiopathic hypertensive anal canal: a place of internal sphincterotomy
Abstract
Background: Hypertensive anal canal is frequently known to be associated with the presence of anal fissure. Based on clinical experience, we hypothesized that idiopathic anal sphincter hypertonia was a condition equivalent to anal fissure, and therefore, it could be treated the same way.
Patient and methods: Sixty-three patients complaining of anal pain without any anal pathology and ten healthy volunteers were examined. All patients underwent clinical evaluation, neurological examination, anorectal manometry, and measurement of pudendal nerve terminal motor latency. All patients with hypertensive anal canal were randomized into three groups. Group I (surgical group) underwent closed lateral sphincterotomy (LS), group II using nitroglycerine ointment (GTN), and group III received injection of botulinum toxin in internal sphincter. Post-procedures data were recorded at follow-up period.
Results: The mean resting anal pressure (MRAP) was significantly higher in the patient group (114.6 +/- 7.4 mmHg) than control group (72.5 +/- 6.6 mmHg, P < 0.001). Anal pain is the main presenting symptoms aggravated by defecation and not relived by analgesics or local anesthetics. After LS, pain visual analogue scale decreased significantly at follow-up period than after chemical sphincterotomy using GTN or BTX (P = 0.001). There was a significant decrease in MRAP postoperatively from 114.6 +/- 7.4 to 70.8 +/- 5.5 mmHg than after using GTN or BTX (P = 0.03).
Conclusion: Idiopathic hypertensive anal canal is a fact and already exists presented by anal pain aggravated by defecation. It can be managed safely by closed lateral sphincterotomy, but chemical sphincterotomy had a minor role in its management.
Similar articles
-
Long-term prospective randomised clinical and manometric comparison between surgical and chemical sphincterotomy for treatment of chronic anal fissure.S Afr J Surg. 2009 Nov;47(4):112-4. S Afr J Surg. 2009. PMID: 20141067 Clinical Trial.
-
Conservative and surgical treatment of chronic anal fissure: prospective longer term results.J Gastrointest Surg. 2010 May;14(5):773-80. doi: 10.1007/s11605-010-1154-6. Epub 2010 Mar 2. J Gastrointest Surg. 2010. PMID: 20195915
-
Topical nitroglycerin versus lateral internal sphincterotomy for chronic anal fissure: prospective, randomized trial.ANZ J Surg. 2005 Dec;75(12):1032-5. doi: 10.1111/j.1445-2197.2005.03493.x. ANZ J Surg. 2005. PMID: 16398803 Clinical Trial.
-
Fissure-in-ano, to divide or not to divide?Acta Chir Belg. 1999 Oct;99(5):215-20. Acta Chir Belg. 1999. PMID: 10582070 Review.
-
Medical treatment of chronic anal fissure. where do we stand on reversible chemical sphincterotomy?Acta Gastroenterol Belg. 2004 Jul-Sep;67(3):265-71. Acta Gastroenterol Belg. 2004. PMID: 15587333 Review.
Cited by
-
Comparative Study Between Trans-perineal Repair With or Without Limited Internal Sphincterotomy in the Treatment of Type I Anterior Rectocele: a Randomized Controlled Trial.J Gastrointest Surg. 2017 Feb;21(2):380-388. doi: 10.1007/s11605-016-3299-4. Epub 2016 Oct 24. J Gastrointest Surg. 2017. PMID: 27778256 Clinical Trial.
-
A prospective, randomized, double-blind study comparing the efficacy of diltiazem, glyceryl trinitrate, and lidocaine for the treatment of anal fissure in children.Pediatr Surg Int. 2012 Apr;28(4):411-6. doi: 10.1007/s00383-011-3048-4. Epub 2012 Jan 3. Pediatr Surg Int. 2012. PMID: 22212494 Clinical Trial.
-
The importance of topical metronidazole in the treatment of acute anal fissure: a double-blind study controlled for prospective randomization.Ann Coloproctol. 2023 Apr;39(2):131-138. doi: 10.3393/ac.2021.00675.0096. Epub 2022 Jan 18. Ann Coloproctol. 2023. PMID: 35038820 Free PMC article.
-
Gastrointestinal Uses of Botulinum Toxin.Handb Exp Pharmacol. 2021;263:185-226. doi: 10.1007/164_2019_326. Handb Exp Pharmacol. 2021. PMID: 32072269 Clinical Trial.
-
Outlet type constipation in adult patients treated with type A botulinum toxin: a cohort study.Int J Colorectal Dis. 2025 Jan 21;40(1):22. doi: 10.1007/s00384-024-04795-5. Int J Colorectal Dis. 2025. PMID: 39838040 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources